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 Abstract 
 Objective: The common single nucleotide polymorphism (SNP) rs9939609 in the fat mass and 
obesity-associated gene ( FTO ) is associated with obesity. As genetic variants associated with 
weight regulation might also be implicated in the etiology of eating disorders, we evaluated 
whether SNP rs9939609 is associated with bulimia nervosa (BN) and anorexia nervosa (AN). 
 Methods: Association of rs9939609 with BN and AN was assessed in 689 patients with AN, 
477 patients with BN, 984 healthy non-population-based controls, and 3,951 population-
based controls (KORA-S4). Based on the familial and premorbid occurrence of obesity in pa-
tients with BN, we hypothesized an association of the obesity risk A-allele with BN.  Results: 
In accordance with our hypothesis, we observed evidence for association of the rs9939609 
A-allele with BN when compared to the non-population-based controls (unadjusted odds ra-
tio (OR) = 1.142, one-sided 95% confidence interval (CI) 1.001– G ; one-sided p = 0.049) and 
a trend in the population-based controls (OR = 1.124, one-sided 95% CI 0.932– G ; one-sided 
p = 0.056). Interestingly, compared to both control groups, we further detected a nominal as-
sociation of the rs9939609 A-allele to AN (OR = 1.181, 95% CI 1.027–1.359, two-sided p = 0.020 
or OR = 1.673, 95% CI 1.101–2.541, two-sided p = 0.015,).  Conclusion: Our data suggest that 
the obesity-predisposing  FTO allele might be relevant in both AN and BN. 
 Copyright © 2012 S. Karger GmbH, Freiburg 
 Introduction 
 Several SNPs in the first intron of the ‘fat mass and obesity-associated´ ( FTO ) gene are 
strongly associated with obesity in young individuals  [1, 2] and in adults  [2–8] . The most 
frequently described SNP in  FTO associated with obesity is rs9939609, which is located 
82.431kb downstream of ATG start codon of  FTO . The association of rs9939609 with obesity 
was discovered by a genome-wide association study (GWAS) for type 2 diabetes mellitus  [3] 
and subsequently was convincingly corroborated by numerous other studies including the 
first GWAS for early onset (extreme) obesity  [1] . Accordingly, since it was first described in 
2007  [3] , the obesity predisposing risk A-allele at rs9939609 has become one of the most 
solidly confirmed risk factors for polygenetic obesity worldwide  [9] . Homozygous carriers 
of the risk A-allele at rs9939609 weigh about 3 kg more and have a 1.67-fold increased odds 
of obesity compared to homozygous carriers of the T-allele  [3] . Whereas the association of 
rs9939609 with obesity is indisputable, uncertainty remains about the potential associ-
ation of this variant with eating disorders such as anorexia nervosa (AN)  [10, 11] and bulimia 
nervosa (BN). We and others have previously hypothesized that genes relevant in weight 
regulation might also be relevant in eating disorders  [12–16] . Premorbid overweight and 
obesity are common in patients with BN, and a familial loading with obesity has also been 
described  [17, 18] . In contrast, premorbid BMI in AN covers the whole BMI range  [19] , and a 
familial predisposition to obesity has not been reported. Accordingly, due to the frequently 
reported premorbid occurrence of obesity in patients with BN, we hypothesized an associ-
ation of the rs9939609 A-allele with BN, whereas for AN we had no specific a priori hypothesis. 
Additionally, we hypothesized that the obesity risk allele at rs9939609 is associated with 
maximum BMI-SDS in patients with these eating disorders. To determine whether the 
rs9939609 obesity risk-allele is associated with BN or AN, we analyzed a total of 6,101 indi-
viduals from three European countries (Germany, Italy, and Spain).
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 Material and Methods  
 Study Subjects 
 The ascertainment strategy was previously described in detail  [13, 20, 21] . Written informed consent 
was given by all participants and, in the case of minors, by their parents. All patients with eating disorders 
were diagnosed according to DSM-IV criteria  [22] . The study was approved by the Ethics Committees of 
the Universities of Marburg, Duisburg-Essen, Heidelberg, Freiburg i.Br., Berlin, Aachen, Milan, Florence, 
and Barcelona  as well as the Helmholtz Center Munich and carried out according to the Declaration of 
Helsinki. 
 In total, the study comprises 6,101 individuals from three European countries (Germany, Italy, and 
Spain). They were recruited at the Departments of Child and Adolescent Psychiatry of the Universities of 
Marburg, Duisburg-Essen, Aachen or Freiburg i.Br., Germany (N = 805); the Charité Hospital Berlin, 
Germany (N = 200); the German Research Center for Environmental Health, Helmholtz Center Munich, 
Neuherberg, Germany (N = 3,951), the Medical Psychosomatic Clinic Roseneck, Germany (N = 90); the 
Department of Psychosomatic Medicine, University of Heidelberg, Germany (N = 48), the Eating Disorders 
Unit of the Department of Psychiatry, University Hospital of Bellvitge, Spain (N = 503); the Neurology Unit 
of the Department of Neurology and Psychiatric Sciences, University of Florence, Italy (N = 232); or at the 
Fondazione Centro San Raffaelle del Monte Tabor, Milan, Italy (N = 272). Anthropometric data of the study 
subjects are listed in  table 1 . 
 The German samples included 103 patients with BN and 348 (10 male) patients with AN; of these 
297 (6 male) individuals had acute AN, and 51 (4 male) were recovered individuals from two long-term 
follow-up studies of AN  [23, 24] . The German controls included 692 non-population-based German 
normal-weight or lean healthy individuals. We chose to also include lean individuals as controls, as their 
BMI is similar to the BMI of patients with AN. Thus, a detected association should be attributable to AN 
rather than to low body weight. In this sample, all individuals with a current eating disorder, like AN or 
Eating Disorder not Otherwise Specified (EDNOS), as assessed by a short version of the Composite Inter-
national Diagnostic Interview (CIDI), were excluded from the study. The CIDI questionnaire was kindly 
provided by Professor Wittchen. In addition, we further compared genotypes of AN and BN cases with a 
second control group that comprised of 3,935 individuals of a population-based cohort (Kooperative 
Gesundheitsforschung im Raum Augsburg, (KORA); i.e. Cooperative Health Research in the Region of 
Augsburg). The KORA sample is a representative study group of the population in the city and region of 
Augsburg (Bavaria, Germany)  [25] . 
 The Italian samples included 261 patients with AN and 243 patients with BN. Italian controls were 
not available. The Spanish samples included 80 patients with AN, 131 patients with BN, and 292 Spanish 
healthy non-population-based controls covering all weight categories ( table 1 ). In total, the 689 patients 
with AN had a mean age of 21.83  8 7.13 years and a mean BMI of 15.87  8 2.77 kg/m². The 477 patients 
with BN had a mean age of 25.10  8 6.51 years and a mean BMI of 23.12  8 5.17 kg/m². 
 Molecular and Genetic Methods  
 Genotyping : The  FTO SNP rs9939609 was either genotyped using ARMS-PCR as described previously 
 [26] , by KASPAR genotyping technology (KBioscience, Hoddesdon, UK), or (in case of the KORA samples) 
by MassARRAY system using iPLEX TM Gold chemistry (Sequenom, San Diego, CA, USA)  [27] . PCR conditions 
and primer sequences can be obtained from the authors. For validity of genotypes, alleles were rated inde-
pendently by at least two experienced individuals. Discrepancies were resolved unambiguously either by 
reaching consensus or by retyping. All missing calls (approximately 2% of all genotyped individuals) were 
successfully re-genotyped. To ensure validity of genotyping between the described methods ,  we geno-
typed rs9939609 twice in 93 individuals; the genotypes were identical. 
 Statistics 
 Hardy-Weinberg equilibrium for all independent study groups was tested with an exact test  [28] . It 
is also noteworthy that the reported genotype and allele frequencies of SNP rs9939609 are very similar 
among samples of European origin, including those from Italy  [3] , Spain  [29, 30] and Germany  [1, 26] . As 
stratification is therefore negligible, previous studies for different phenotypes have assessed association 
of rs9939609 in combined samples of European origin  [31, 32] . Accordingly, the case-control analyses 
reported here were also initially analyzed, irrespective of their origin; subsequent analyses were strat-
ified by country (with the exception of the Italian cases due to a lack of controls from the same country). 
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This post-hoc stratification of the samples was performed after obtaining a nominally significant result at 
level   = 0.05 for the global test. The reasons for stratification were to explore the robustness of the asso-
ciation across subsamples and to analyze the association, as far as possible, in subsamples in which the 
possibility of population stratification is reduced. For this reason, odds ratio (OR) estimates and nominal 
p-values from each subsample are unadjusted for multiple testing and not intended to provide confir-
matory evidence at the 0.05 significance level. 
 The maximum BMI-SDS values were calculated in both German children/adolescents and German 
adults for which maximum BMI values were available. The maximum lifetime BMI was assessed by stan-
dardized questionnaires upon patient assessment. The patients were asked for their highest lifetime body 
weight and the corresponding age. As we previously showed that body height does not alter considerably 
after 13 years of age  [19] , we used the measured height at referral for the maxixum BMI estimations. Based 
on the German age-related reference data  [33, 34] , the degree of maximum lifetime BMI was then quan-
tified with Cole’s least mean square method  [35] , which normalized the BMI taking gender and age into 
account, resulting in a standard deviation score (BMI-SDS).  
 For the case-control comparisons with regard to the obesity risk A-allele at rs9939609, we applied 
the Cochran-Armitage trend test and logistic regression without and with covariates BMI and age. For the 
outcome maximum BMI-SDS in BN and AN patients we applied Jonckheere’s non-parametric trend test. We 
used a (log-)linear genetic model. Consistent with our unidirectional hypothesis that obesity is a risk 
factor for BN, we decided to display one-sided p-values for BN and two-sided p-values for AN in the case-
control comparisons, whereas we reported one-sided p-values for the assessment of maximum BMI-SDS. 
All reported p-values are nominal and not adjusted for multiple testing, and we applied a level   = 0.05 for 
each test. 
Group  Variable German samples Italian samples Spanish samples  
AN  N 297  
(6 males)1 
51  
(4 males)2 
261 80 
  age 18.35 ± 6.51 33.03 ± 7.473 
16.20 ± 2.004 
25.02 ± 6.26 24.03 ± 6.19 
   BMI 16.07 ± 2.92 20.83 ± 2.405 
14.50 ± 1.606 
14.77 ± 2.11 16.97 ± 1.91 
BN  N 103  243 131 
  age 24.28 ± 7.10  25.10 ± 6.50 25.77 ± 6.03 
   BMI 22.80 ± 6.65  22.40 ± 4.20 24.06 ± 4.78 
Controls  N 6927 3,9518  2929 
  age 24.69 ± 5.55 49.16 ± 13.89   
   BMI 19.62 ± 2.00 27.22 ± 4.72   
1Acute patients with AN. 
2Recovered patients with AN. 
3Current age. 
4Age of first admission. 
5BMI after recovery.  
6BMI at first admission. 
7Non-population-based lean controls. 
8Population-based controls. 
9Spanish controls covering the whole BMI range.  
 
Table 1. Anthropometric characteristics of study samples
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 For BN, 477 cases and 984 European non-population-based controls were estimated  [36] to yield a 
power of  1 0.80 to detect a multiplicative genotype-relative risk (GRR) of 1.27 (assuming a minor allele 
frequency (MAF) of 0.4). For the comparison with the 3,951 population-based controls, power estimates 
were  1 0.80 for a multiplicative GRR of 1.24 (again assuming a MAF of 0.4). For AN, power estimates for 
689 cases and 984 non-population-based controls were  1 0.80 for a multiplicative GRR of 1.24 and  1 0.80 
for a multiplicative GRR of 1.20 compared to the 3,951 population-based controls (again assuming a MAF 
of 0.4). 
 Results  
 Association of rs9939609 with BN  
 The combined analysis of all patients with BN (n = 477) and all non-population-based 
controls (n = 984) revealed an association of the rs9939609 obesity risk-allele (A) with BN 
(the unadjusted effect size estimate for the risk allele was an OR of 1.142, one-sided 95% 
confidence interval (CI) 1.001– G ; one-sided p = 0.049, 95%;  table 2 ). Even though not statis-
tically significant, a similar trend was observed when comparing all patients with BN with 
the 3,951 individuals of the population-based KORA-S4 cohort (one-sided p = 0.056;  table 1 ). 
This trend did not change after exclusion of the 9 male subjects (468 cases and 3,951 controls; 
OR: 1.120, one-sided 95% CI 0.999– G ; p = 0.052, data not shown).
 We also compared the patients with BN with the 3,951 population-based controls in a 
logistic regression model. In the case of BN, the unadjusted OR was 1.124 (one-sided 95% CI 
1.003– G ; one-sided p = 0.046) and adjustment for age and BMI led to OR = 1.120 (one-sided 
95% CI 0.932– G ; one-sided p = 0.155). Thus, the results were similar to the initial associ-
ation test based on the Cochran-Armitage trend test (one-sided p = 0.056;  table 2 ). The 
analyses stratified by country revealed that this observation was also consistent across 
subgroups with the exception of the German subgroup where no trend for differences in 
allele frequencies was observable ( table 2 ). 
 In patients with BN we, however, observed no association of the obesity-predisposing 
risk A-allele at rs9939609 with BMI-SDS (TT 0.214  8 1.24, TA 0.406  8 1.49, AA 0.753  8 
1.89; one-sided p = 0.094). 
 Association of rs9939609 with AN  
 In the case-control analysis including all patients with AN (n = 689) and all non-popu-
lation-based controls (n = 984), we unexpectedly observed a nominal association of the 
A-allele at rs9939609 with AN (unadjusted OR = 1.181, 95% CI 1.027–1.359, two-sided p = 
0.020,  table 3 ). This association was also seen after exclusion of all 29 male subjects (660 
cases and 3,951 controls; OR: 1.176, 95% CI 1.021–1.354; two-sided p = 0.025; data not 
shown). 
 Again, we also compared the patients with AN with the 3,951 population-based indi-
viduals and observed an unadjusted OR = 1.176 (95% CI 1.044–1.326; two-sided p = 0.008) 
and age- and BMI-adjusted OR = 1.673 (95% CI 1.101–2.541; two-sided p = 0.016). Thus, the 
results for AN were also similar to the initial association test based on the Cochran-Armitage 
Test (two-sided p = 0.015;  table 3 ). The stratified analyses revealed that this finding was 
robust across subsamples. 
 Association of rs9939609 with Maximum BMI-SDS in Eating Disorders 
 The maximum BMI-SDS values were available for 105 German patients with BN and 214 
German patients with AN. However, the trend test comparing the maximum BMI-SDS values 
revealed no evidence for an association of the rs9939609 obesity risk A-allele with increased 
maximum BMI-SDS in patients with BN or AN (nominal p = 0.066 or p = 0.180;  table 4 ). 
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 Table 2. Case-control association studies in 477 patients with BN, 984 normal-weight and lean controls 
(European non-population-based controls) as well as 3,951 population-based controls for rs9939609 in 
the  FTO 
Sample N Genotypes N1  
(frequency %) 
Alleles, % HWE 
p-value 
p-value2 
All European BN cases 477  TT: 153 (32.1) 
TA: 235 (49.3) 
AA: 89 (18.7) 
T: 56.7 
A: 43.3 
1.00  
European non-population-based controls 984  TT: 350 (35.6) 
TA: 479 (48.6) 
AA: 155 (15.8) 
T: 59.9 
A: 40.1 
0.742 0.0493 
German population-based controls5 3,951  TT: 1,392 (35.2) 
TA: 1,909 (48.3) 
AA: 650 (16.5) 
T: 59.4 
A: 40.6 
0.947 0.0564 
Subsample  
German BN cases 
103 TT: 35 (34.0) 
TA: 55 (53.4) 
AA: 13 (12.6) 
T: 60.7 
A: 39.3 
0.302 0.546 
Subsample  
German non-population-based controls 
692  TT: 249 (36.0) 
TA: 336 (48.6) 
AA: 107 (15.5) 
T: 60.3 
A: 39.7 
0.751  
Subsample  
Italian BN cases 
243  TT: 79 (32.5) 
TA: 117 (48.1) 
AA: 47 (19.3) 
T: 56.6 
A: 43.4 
0.794 0.091 
Subsample  
European non-population-based controls  
984  TT: 350 (35.6) 
TA: 479 (48.6) 
AA: 155 (15.8) 
T: 59.9 
A: 40.1 
0.691  
Subsample  
Spanish BN cases 
131  TT: 39 (29.8) 
TA: 63 (48.1) 
AA: 29 (22.1) 
T: 53.8 
A: 46.2 
0.726 0.077 
Subsample  
Spanish non-population-based controls 
292  TT: 101 (34.6) 
TA: 143 (49.0) 
AA: 48 (16.4) 
T: 59.1 
A: 40.9 
0.904  
1No evidence for deviations from Hardy-Weinberg equilibrium (p>0.05). 
2One-sided uncorrected p-values. 
3Unadjusted estimated OR and 95% one-sided CI is: OR 1.142, 95% CI 1.001–∞. 
4Estimated OR and 95% one-sided CI with and without adjustment for age and BMI is: OR 1.120, 95% 
CI 1.003–∞ and OR 1.124, 95% CI 0.932–∞, respectively. 
5Note that in the 3,951 population-based controls we also observed an additive effect of the obesity 
risk A-allele for increased BMI (mean BMI AA: 27.67 ± 4.73, AT: 27.25 ± 4.75 , TT: 27.00 ± 4.65, mean BMI 
increase per A-allele 0.3206 ± 0.1085 p=0.0032).  
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 Discussion 
 Genetic variation (e.g. at rs9939609) in the  FTO has repeatedly been shown to be asso-
ciated with obesity  [1–8] . Based on our results we argue that the gene might also be relevant 
for eating disorders. Increased rates of both premorbid and familial overweight and obesity 
have been described in patients with BN  [17, 18] , whereas in patients with AN the premorbid 
BMI has been shown to cover the whole BMI distribution  [37] . Hence, we had the a priori 
 Table 3. Case-control association studies in 689 patients with AN, 984 normal-weight and lean controls 
(European non-population-based controls) as well as 3,951 population-based controls for rs9939609 in 
the  FTO 
Sample N Genotypes N 
(frequency %)1 
Alleles,% HWE 
p-value 
p-value2 
All European AN cases 689  TT: 216 (31.3) 
TA: 338 (49.1) 
AA: 135 (19.6) 
T: 55.9 
 
A: 44.1 
0.9384  
European non-population-based controls 984  TT: 350 (35.6) 
TA: 479 (48.6) 
AA: 155 (15.8) 
T: 59.9 
 
A: 40.1 
0.691 0.0203 
German population-based controls 3,951  TT: 1,392 (35.2) 
TA: 1,909 (48.3) 
AA: 650 (16.5) 
T: 59.4 
 
A: 40.6 
0.947 0.0154 
German AN cases 348  TT: 117 (33.6) 
TA: 161 (46.3) 
AA: 70 (20.1) 
T: 56.8 
 
A: 43.2 
0.277 0.127 
German non-population-based controls 692  TT: 249 (36.0) 
TA: 336 (48.6) 
AA: 107 (15.5) 
T: 60.3 
 
A: 39.7 
0.751  
Italian AN cases 261  TT: 79 (30.3) 
TA: 129 (49.4) 
AA: 53 (20.3) 
T: 55.0 
 
A: 45.0 
1.000 0.041 
European non-population-based controls 984  TT: 350 (35.6) 
TA: 479 (48.6) 
AA: 155 (15.8) 
T: 59.9 
 
A: 40.1 
0.691  
Spanish AN cases 80  TT: 20 (25.0) 
TA: 48 (60.0) 
AA: 12 (15.0) 
T: 55.0 
 
A: 45.0 
0.074 0.341 
Spanish non-population-based controls 292  TT: 101 (34.6) 
TA: 143 (49.0) 
AA: 48 (16.4) 
T: 59.1 
 
A: 40.9 
0.904  
1No evidence for deviations from Hardy-Weinberg equilibrium (p > 0.05). 
2Two-sided uncorrected p-values. 
3Estimated unadjusted OR and 95% CI are: OR 1.180, 95% CI 1.027–1.357. 
4Estimated unadjusted and adjusted OR and 95% CI are: OR 1.176, 95% CI 1.044–1.326 and OR 1.673; 
95% CI 1.101–2.541, respectively. 
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directional hypothesis that the obesity risk allele is implicated in BN and tested accordingly. 
We observed a nominally significant association of the rs9939609 A-allele in 477 patients 
with BN compared to 984 non-population-based controls (one-sided p = 0.049). For AN we 
had no specific a priori hypothesis. Nevertheless, for 689 patients with AN compared to 984 
non-population-based controls we observed evidence for an association of the  FTO obesity 
risk allele with AN (two-sided p = 0.020). Eating disorders are typically characterized by 
diagnostic instability, migration between different subtypes, and even between different 
eating disorders  [38, 39] . However, whereas several studies consistently show that 25–30% 
of patients with eating disorder migrate from AN to BN, migration from BN to AN is less 
frequently described  [39, 40] . Therefore, it is unlikely that the observed association of the 
rs9939609 A-allele with AN can be explained by AN patients with a history of BN. However, 
one of the limitations of our study is that detailed amnesic information, especially regarding 
previous eating disorders as well as follow-up data, was not available. Furthermore, even 
though substantial evidence indicates that stratification is, due to the very similar allele 
frequencies of rs9939609 among Europeans  [1, 3, 29, 30] , negligible, the lack of Italian 
controls as well as the lack of anthropometric characteristics for the Spanish controls are 
other limitations of this study. Noteworthy, excluding the 243 Italian BN cases from our 
analysis (and thus decreasing the sample size by 49.1% from 477 to 234 patients with BN) 
would yield a nominal one-sided p-value of 0.110 for the comparison of the remaining 234 
European BN cases versus 984 non-population based controls (OR 1.137, one-sided 95% CI 
0.957– G ) and a nominal one-sided p-value of 0.137 for the comparison with the 3,951 
German population-based controls (OR 1.111, one-sided 95% CI 0.948– G ). Exclusion of the 
261 Italian patients with AN (and thus decreasing the sample size by 37.9% from 689 to 428 
patients with AN) would yield a nominal two-sided p-value of 0.083 for the comparison of 
the remaining 428 patients with AN versus the 984 European non-population based controls 
(OR 1.155; 95% CI 0.981–1.360) and a nominal two-sided p-value of 0.094 for the comparison 
with the 3,951 German population-based controls. As solid evidence indicates that there are 
no stratification effects of rs9939609 among samples from Italy, Spain and Germany, the 
observed loss of significance is likely to be attributable to the dramatic loss of statistical 
power. Accordingly, to maximize the statistical power we choose to keep the Italian samples 
in our analysis. However, further studies are warranted to independently confirm our 
results and to analyze if, and to what extent, the association of the  FTO risk allele is dependent 
 Table 4. Quantitative compari -
son of maximum BMI-SDS values 
in patients with AN or BN de -
 pendent on the rs9939609 geno -
type in the  FTO 
Sample Genotypes N (%) Maximum BMI-SDS p-value1 
AN + BN TT 95 (29.8) 0.758 ± 1.290 0.066 
 TA 162 (50.8) 0.912 ± 1.771  
 AA 62 (19.4) 1.367 ± 1.951  
BN TT 33 (31.4) 1.405 ± 1.496 0.066 
 TA 53 (50.5) 2.070 ± 2.159  
 AA 19 (18.1) 2.710 ± 2.553  
AN TT 62 (29.0) 0.414 ± 1.021 0.180 
 TA 109 (50.9) 0.348 ± 1.206  
 AA 43 (20.1) 0.772 ± 1.248  
1Uncorrected p-value of the Jonckheere’s non-parametric trend 
test. Note that the A-allele is the obesity risk allele. 
 
D
ow
nl
oa
de
d 
by
: 
Un
iv 
St
ud
i F
ire
nz
e 
   
   
   
   
   
   
   
   
   
   
   
   
15
0.
21
7.
72
.1
46
 - 
4/
4/
20
17
 1
0:
58
:1
2 
AM
416Obes Facts 2012;5:408–419
 DOI: 10.1159/000340057 
 Published online: June 27, 2012 
 Müller et al.: Fat Mass and Obesity-Associated Gene ( FTO ) in Eating Disorders: 
Evidence for Association of the rs9939609 Obesity Risk Allele with Bulimia nervosa 
and Anorexia nervosa 
www.karger.com/ofa
© 2012 S. Karger GmbH, Freiburg
on the DSM-IV AN and BN subtypes and the transversion of AN into BN (and vice versa). 
Another interesting aspect is the possible confounding effect of the behavioral influences 
on BMI in AN and BN patients. Since low BMI possibly influenced by  FTO alleles will make 
individuals with eating disorders more likely to be diagnosed and become cases, this could 
be one potential source of confounding due to BMI in our analyses.
 Besides a recent publication on the absence of an association of genetic variation in  FTO 
in a sample of 267 patients with AN and 1,636 population-based controls  [10] , three studies 
investigated the effect of  FTO variants on eating behavior  [41–43] . Whereas, after adjustment 
for age and BMI, no association was found between rs9939609 and energy expenditure  [41] , 
two studies indicated a BMI-independent association of the rs9939609 risk A-allele with 
increased energy intake  [41, 42] and decreased satiety  [43] . Similarly, our observed asso-
ciation of  FTO with AN might be independent of the elevating effect of this variant on BMI 
as based on our regression analysis including BMI as a quantitative covariate. Alternatively, 
it is possible that both a weight-elevating effect of the risk A-allele and a modulation of eating 
behavior and satiety accounts for the observed associations. Noteworthy, a recent publi-
cation further reports no association of  FTO variants with psychological and behavioral 
eating disorder phenotypes, such as anxiety, harm avoidance, novelty seeking, impulsivity, 
obsessionality, compulsivity, and concern over mistakes  [11] .
 A subgroup of the German non-population-based controls was lean (BMI below the 15th 
BMI percentile) and might thus have biased our analyses due to the established association 
of rs9939609 with obesity. Hence, we added a comparison of AN and BN cases with 3,951 
individuals of a German population-based cohort (KORA) and adjusted for BMI and age. 
These analyses supported the aforementioned findings. It is further noteworthy that within 
the 3,951 population-based controls we also observed a significant additive effect of the 
obesity risk A-allele for an increased BMI (mean BMI AA 27.67  8 4.73, AT 27.25  8 4.75 TT 
27.00  8 4.65, mean BMI increase per A-allele 0.321  8 0.109; p = 0.0032). Noteworthy, this 
trend was robust after adjustment for age and gender (mean increase per A-allele 0.329  8 
0.104; p = 0.0016).
 We also hypothesized that the risk allele (A) for obesity at rs9939609 is associated with 
maximum BMI-SDS in patients with BN or AN. Analyses of maximum BMI-SDS values of indi-
viduals carrying either one, two, or no risk A-allele at rs9939609 revealed, however, no asso-
ciation of the obesity risk A-allele with maximum BMI-SDS in patients with either BN or AN 
(one-sided p = 0.066 or 0.180). 
 In summary, we observed evidence for an association of the A-allele at rs9939609 with 
both AN and BN. In patients with AN, the association was robust after adjustment for BMI 
and age. While the observation for AN was unexpected, the observed association of the 
obesity-predisposing risk A-allele with BN is in line with previous findings  [17, 18] . As 
obesity is a risk factor for the development of BN, obesity risk alleles should be more frequent 
in patients with BN. We conclude that genetic variation in  FTO might be implicated in the 
etiology of BN and AN. However, additional research is warranted to determine whether the 
risk allele has a direct, indirect, or synergistic effect on eating disorders. The trend observed 
for association with maximum BMI-SDS in patients with BN suggests that for this eating 
disorder the association is indirect or synergistic. To address this question, we also analyzed 
the effect of  FTO alleles on BN after adjusting for age and maximum BMI. The caveat of this 
approach is, however, that many of the lean controls were recruited for low current BMI 
which is strongly correlated with the maximum BMI of these patients. To control for this 
bias we adjusted our data for current BMI, revealing a nonsignificant estimated effect from 
the  FTO risk A-allele (OR 0.888, 95% CI 0.601–1.312; p = 0.552) and a significant effect from 
max BMI (OR 2.134, 95% CI: 1.779–2.560; p  ! 0.001), thus identifying that the effect of  FTO 
on BN is indeed indirect.
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